Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited (ADVENZYMES) is a micro-cap Healthcare company valued at ₹2,982 crore operating in Biotechnology on the NSE and BSE.

Recent price move

Advanced Enzyme Technologies Limited last traded at ₹268.3, up 2.05% on the day.

Recent developments

On 2026-08-04, the company partnered with Biocon to leverage government initiatives like BioE3 and Biopharma SHAKTI, which aim to boost India's biotechnology sector. This collaboration is expected to enhance the company's position in the growing biopharma landscape.

Financial performance

The company's business is improving, with annual revenue rising 17.1% and net profit growing 29.6% year-over-year. However, the latest quarter showed a slight decline in net profit compared to the same quarter a year earlier, while revenue grew marginally.

Valuation multiples

The stock trades at 17.8 times earnings, a discount to the Healthcare median of 32.0, 2.08 times book value. It yields 1.8%.

Things to watch

The stock is 34.5% below its 52-week high, indicating a significant pullback from recent peak levels. Net profit in the latest quarter fell 3.5% compared to the same quarter a year earlier, despite revenue growth.

Where it stands

Advanced Enzyme Tech Ltd has shown strong growth in annual revenue and net profit, with a rising net profit margin. However, the latest quarter's net profit decline contrasts with the annual trend. The stock remains 34.5% below its 52-week high, highlighting recent underperformance.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.